The development, refinement, and psychometric testing of the attitude toward advanced directive survey in implantable cardioverter defibrillator patients

Journal of Cardiovascular Nursing

Volumn 28, Issue 3, 2013, Pages 238-244

  Conelius, Jaclyn ^a  

^a FAIRFIELD UNIVERSITY   (United States)

Author keywords

Advanced directives; Implantable cardioverter defibrillators; Quality of life; Survey development

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; FACTORIAL ANALYSIS; FEMALE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIVING WILL; MALE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; TREATMENT WITHDRAWAL; UNITED STATES; VALIDATION STUDY; VERY ELDERLY;

ADVANCE DIRECTIVES; AGED; AGED, 80 AND OVER; CONNECTICUT; DEFIBRILLATORS, IMPLANTABLE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; WITHHOLDING TREATMENT;

EID: 84876468596     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e31824b2105     Document Type: Article

References (29)

1. Fauchier L, de Labriolle A. Research in resuscitation from cardiac arrest: where should we go from here? Crit Care Med. 2003;35: 1436-1437.
2. Kurtz S, Ochoa J, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33: 1-7.
3. Antezano E, Hong M. Sudden cardiac death. J Intensive Care Med. 2003;18: 313-329.
4. Bansch D, Antz M, Boczor S. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002; 105: 1453.
5. Dietmar B, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. Circulation. 2002;105: 1453-1458.
6. Moss A, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl JMed. 2002;346: 877-883.
7. Bigger JT; for the CABG Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med. 1997;337: 1569-1575.
8. Connolly SJ, Hallstrom AP, Schron K, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Soc Cardiol. 2000;21: 2071-2078.
9. Epstein AE, Dimarco JP, Ellenbogen KA. ACC/AHA/HRS 2008 guidelines for device therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force of Practice Guidelines developed in collaboration with the American Association of Thoracic Surgery and Society of Thoracic Surgeons. Available at American College of Cardiology Web site. www .acc.org. Accessed June 1, 2011.
10. Hohnloser SH, Kuck KH, Dorian O, et al. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med. 2004;351: 2481.
11. Ballentine JM. Pacemaker and defibrillator deactivation in competent hospice patients: an ethical consideration. Am J Hosp Palliat Med. 2005;22: 14-19.
12. Berger JT. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med. 2005;142: 631-634.
13. Jacobson J, White B, Battin M, Francis L, Green D, Kasworm E. Patients' understanding and use of advanced directives. West J Med. 2004;160: 232-236.
14. Brown BA. The history of advanced directives: a literature review. J Gerontol Nurs. 2003;29: 4-14.
15. Scherer Y, Jezewski M, Graves B, Wu Y, Bu X. Advance directives and end-of-life decision making. Crit Care Nurse. 2006;26: 30-40.
16. Stetler K, Elliott B, Bruno C. Living will completion in older adults. Arch Intern Med. 1992;152: 954-959.
17. Crane M, Wittink M, Doukas D. Respecting end-of-life treatment preferences. Am Acad Fam Physician. 2005;72: 1263-1270.
18. Crego PJ, Lipp EJ. Nurses' knowledge of advanced directives. Am J Crit Care Nurses. 1998;7: 218-223.
19. Cugliari AM, Miller JD, Sobal J. Factors promoting completion of advance directives in the hospital. Arch Intern Med. 1995;155: 1893-1998.
20. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end of life care. Ann Intern Med. 2004;141: 835-838.
21. Wissow L, Belote A, Kramer W, et al. Promoting advance directives among elderly primary care patients. J Gen Intern Med. 2004;19: 944-951.
22. Gross MD. What do patients express as their preferences in advanced directives? Arch Intern Med. 1997;158: 363-365.
23. Berger JT, Gorski M, Cohen T. Advance health planning and treatment. preferences among recipients of implantable cardioverter defibrillators: an exploratory study. J Clin Ethics. 2006;17: 72-78.
24. Heiman H, Bates D, Fairchild D, Shaykevich S, Lehmann L. Improving completion of advanced directives in primary care setting: a randomized control trial. Am J Med. 2004;117: 318-324.
25. Conelius J. Literature review: advanced directives and patients with implantable cardioverter defibrillator. J Am Acad Nurse Pract. 2010;22(5): 250-255.
26. Statistical Package for the Social Sciences {SPSS}; 16.0. Chicago, IL: SPSS; 2007.
27. LewisW, Luebke D, Johnson N, HarringtonM, Constantini O, Aulisio M. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119: 892-896.
28. DeVellis RF. Scale Development: Theory and Applications. Newbury Park, CA: Sage; 2003.
29. Gable R, Wolf M. Instrument Development in the Affective Domain. Boston, MA: Kluwer Academic Publishers; 1993.